Survodutide is an innovative dual agonist targeting GLP-1 and glucagon receptors. In research settings, it shows strong effects on appetite regulation, fat oxidation, and energy expenditure, making it a promising candidate for studies on obesity and metabolic disorders. Preclinical data indicate significant weight reduction and improved glucose control. This material is intended strictly for laboratory and educational purposes and is not approved for human or veterinary use.
PRODUCT NOT IN STOCK. CONTACT SUPPORT FOR MORE INFORMATION.
SHARE:
Products sold on our website are designed for in vitro testing and lab experimentation exclusively.
All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
Useful links
Our support team is at your service, ensuring customer satisfaction.
Our support team is at your service, ensuring customer satisfaction.
